Tumor necrosis factor receptor superfamily member 5
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain R; UniProt 21–193 | Not recorded | Bleselumab, heavy chain × 1 Bleselumab, light chain × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium chloride 20% w/v Polyethylene glycol 3,350 | Resolution 2.70 Å R-free 0.265 |
| 2 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain C; UniProt 21–193 | Not recorded | Bleselumab, heavy chain × 1 Bleselumab, light chain × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium chloride 20% w/v Polyethylene glycol 3,350 | Resolution 2.70 Å R-free 0.265 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 8YX1 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1CZZ STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE Deposited 1999-09-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain D
250–258(9 aa)
Fragment:TRAF2-BINDING REGION
Chain E
250–258(9 aa)
Fragment:TRAF2-BINDING REGION
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;293 K;PEG4K, MES, PH 5.6, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.70 Å R-free 0.267 |
| 1D00 STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE Deposited 1999-09-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain I
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å R-free 0.254 |
| 1D00 STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE Deposited 1999-09-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain K
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain L
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain M
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å R-free 0.254 |
| 1D00 STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE Deposited 1999-09-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain N
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain O
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain P
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å R-free 0.254 |
| 1D00 STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE Deposited 1999-09-07 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain J
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å R-free 0.254 |
| 1FLL MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3 Deposited 2000-08-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain X
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å R-free 0.312 |
| 1FLL MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3 Deposited 2000-08-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain Y
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å R-free 0.312 |
| 1FLL MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3 Deposited 2000-08-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain Y
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å R-free 0.312 |
| 1LB6 TRAF6-CD40 Complex Deposited 2002-04-02 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
230–238(9 aa)
Fragment:residues 230-238
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;PEG8000, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.80 Å R-free 0.258 |
| 3QD6 Crystal structure of the CD40 and CD154 (CD40L) complex Deposited 2011-01-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain R
21–190(170 aa)
Fragment:extracellular domain
Chain S
21–190(170 aa)
Fragment:extracellular domain
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;295 K;12% PEG6000, 0.1M MOPS, 10% isopropanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.50 Å R-free 0.298 |
| 3QD6 Crystal structure of the CD40 and CD154 (CD40L) complex Deposited 2011-01-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain T
21–190(170 aa)
Fragment:extracellular domain
Chain U
21–190(170 aa)
Fragment:extracellular domain
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;295 K;12% PEG6000, 0.1M MOPS, 10% isopropanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.50 Å R-free 0.298 |
| 5DMI Structure of the extracellular domain of the CD40 in complex with CHI220 FAB Deposited 2015-09-08 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
23–193(171 aa)
Fragment:Extracellular domain residues 23-193
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;80mM sodiym acetate, pH 4.6, 1.6 M ammonium sulfate, 20% (v/v) glycerol
|
Resolution 3.69 Å R-free 0.207 |
| 5DMJ Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB Deposited 2015-09-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
23–193(171 aa)
|
Mutation:D153, D180 | K POTASSIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å R-free 0.258 |
| 5DMJ Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB Deposited 2015-09-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
23–193(171 aa)
|
Mutation:D153, D180 | K POTASSIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å R-free 0.258 |
| 5DMJ Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB Deposited 2015-09-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
23–193(171 aa)
|
Mutation:D153, D180 | K POTASSIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å R-free 0.258 |
| 5IHL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB Deposited 2016-02-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å R-free 0.298 |
| 5IHL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB Deposited 2016-02-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å R-free 0.298 |
| 5IHL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB Deposited 2016-02-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å R-free 0.298 |
| 5IHL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB Deposited 2016-02-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å R-free 0.298 |
| 6FAX Complex of Human CD40 Ectodomain with Lob 7.4 Fab Deposited 2017-12-18 | Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain R
21–193(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;NA
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;NA
|
Resolution 2.99 Å R-free 0.231 |
| 6PE8 Crystal structure of CD40/ABBV-323 FAB complex Deposited 2019-06-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain U
21–193(173 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;2M ammonium sulfate, 0.1M phosphate-citrate pH 4.2
|
Resolution 2.84 Å R-free 0.265 |
| 6PE8 Crystal structure of CD40/ABBV-323 FAB complex Deposited 2019-06-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain T
21–193(173 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;2M ammonium sulfate, 0.1M phosphate-citrate pH 4.2
|
Resolution 2.84 Å R-free 0.265 |
| 6PE9 Crystal Structure of CD40 complexed to FAB516 Deposited 2019-06-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain I
21–193(173 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å R-free 0.255 |
| 6PE9 Crystal Structure of CD40 complexed to FAB516 Deposited 2019-06-20 | Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
21–193(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å R-free 0.255 |
| 6PE9 Crystal Structure of CD40 complexed to FAB516 Deposited 2019-06-20 | Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain U
21–193(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å R-free 0.255 |
| 6PE9 Crystal Structure of CD40 complexed to FAB516 Deposited 2019-06-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain V
21–193(173 aa)
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å R-free 0.255 |
| 6PE9 Crystal Structure of CD40 complexed to FAB516 Deposited 2019-06-20 | Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain J
21–193(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å R-free 0.255 |
| 7P3I Crystal structure of human CD40/TNFRSF5 in complex with the anti-CD40 DARPin protein Deposited 2021-07-07 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
21–193(173 aa)
Fragment:>FRAGMENT<
|
Not recorded | NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;29.9999 %w/v PEG 4K, 0.24 M LiSO4, 0.0999 M TRIS, 0.35 M NaBr
|
Resolution 2.29 Å R-free 0.253 |
| 7P3I Crystal structure of human CD40/TNFRSF5 in complex with the anti-CD40 DARPin protein Deposited 2021-07-07 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
21–193(173 aa)
Fragment:>FRAGMENT<
|
Not recorded | NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;29.9999 %w/v PEG 4K, 0.24 M LiSO4, 0.0999 M TRIS, 0.35 M NaBr
|
Resolution 2.29 Å R-free 0.253 |
| 8YX9 CD40 in complex with Dacetuzumab Fab Deposited 2024-04-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
21–193(173 aa)
|
Not recorded | GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å R-free 0.262 |
| 8YX9 CD40 in complex with Dacetuzumab Fab Deposited 2024-04-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain J
21–193(173 aa)
|
Not recorded | GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å R-free 0.262 |
| 8YX9 CD40 in complex with Dacetuzumab Fab Deposited 2024-04-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain D
21–193(173 aa)
|
Not recorded | GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å R-free 0.262 |
| 8YX9 CD40 in complex with Dacetuzumab Fab Deposited 2024-04-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain K
21–193(173 aa)
|
Not recorded | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å R-free 0.262 |
13 other PDB entries and 33 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | TNR5_HUMAN |
| Isoform | — |
| PDB entities | 3 |
| Chains and sequence ranges | Author chain C; PDBConstruct 1–173; UniProt 21–193 Author chain R; PDBConstruct 1–173; UniProt 21–193 |